Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients.

Frazee BW, Rodríguez-Hoces de la Guardia A, Alter H, Chen CG, Fuentes EL, Holzer AK, Lolas M, Mitra D, Vohra J, Dekker CL.

Ann Emerg Med. 2018 Apr;71(4):509-517.e1. doi: 10.1016/j.annemergmed.2017.09.010. Epub 2017 Nov 24.


A structure-activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins.

Nyffeler J, Chovancova P, Dolde X, Holzer AK, Purvanov V, Kindinger I, Kerins A, Higton D, Silvester S, van Vugt-Lussenburg BMA, Glaab E, van der Burg B, Maclennan R, Legler DF, Leist M.

Arch Toxicol. 2017 Nov 21. doi: 10.1007/s00204-017-2125-4. [Epub ahead of print]


Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity.

Waldmann T, Grinberg M, König A, Rempel E, Schildknecht S, Henry M, Holzer AK, Dreser N, Shinde V, Sachinidis A, Rahnenführer J, Hengstler JG, Leist M.

Chem Res Toxicol. 2017 Apr 17;30(4):905-922. doi: 10.1021/acs.chemrestox.6b00259. Epub 2016 Dec 21.


Asymmetric Biocatalytic Amination of Ketones at the Expense of NH3 and Molecular Hydrogen.

Holzer AK, Hiebler K, Mutti FG, Simon RC, Lauterbach L, Lenz O, Kroutil W.

Org Lett. 2015 May 15;17(10):2431-3. doi: 10.1021/acs.orglett.5b01154. Epub 2015 May 6.


The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.

Pachynski RK, Zabel BA, Kohrt HE, Tejeda NM, Monnier J, Swanson CD, Holzer AK, Gentles AJ, Sperinde GV, Edalati A, Hadeiba HA, Alizadeh AA, Butcher EC.

J Exp Med. 2012 Jul 30;209(8):1427-35. doi: 10.1084/jem.20112124. Epub 2012 Jul 2.


Expression of the human copper influx transporter 1 in normal and malignant human tissues.

Holzer AK, Varki NM, Le QT, Gibson MA, Naredi P, Howell SB.

J Histochem Cytochem. 2006 Sep;54(9):1041-9. Epub 2006 May 18.


Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.

Safaei R, Katano K, Larson BJ, Samimi G, Holzer AK, Naerdemann W, Tomioka M, Goodman M, Howell SB.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):756-67.


Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.

Holzer AK, Katano K, Klomp LW, Howell SB.

Clin Cancer Res. 2004 Oct 1;10(19):6744-9.


The role of copper transporters in the development of resistance to Pt drugs.

Safaei R, Holzer AK, Katano K, Samimi G, Howell SB.

J Inorg Biochem. 2004 Oct;98(10):1607-13. Review.


Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB.

Clin Cancer Res. 2004 Jul 15;10(14):4661-9.


The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.

Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R, Howell SB.

Mol Pharmacol. 2004 Oct;66(4):817-23. Epub 2004 Jun 30.


Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.

Samimi G, Katano K, Holzer AK, Safaei R, Howell SB.

Mol Pharmacol. 2004 Jul;66(1):25-32.


Patient mutations in doublecortin define a repeated tubulin-binding domain.

Taylor KR, Holzer AK, Bazan JF, Walsh CA, Gleeson JG.

J Biol Chem. 2000 Nov 3;275(44):34442-50.

Supplemental Content

Loading ...
Support Center